PRESENTATION ON INTERIM

EVALUATION OF MANAGEMENT
THESIS

SUBMITTED TO:- MR. AJAY

PATOLE

PRESENTED BY:- ASHISH RAHATE

(8NBNG169)
 A

Thesis on

“TO STUDY PROMOTIONAL

STRATEGY ADOPTED BY RANBAXY
LABORATORIES LTD RELATED TO
RANITIDINE-150mg (Antiulcerant) IN
NAGPUR CITY”
 INTRODUCTION

OBJECTIVES:-


To study the overview of Indian Pharmaceutical

Market.
To study the culture of Ranbaxy Lab.
To find out the promotional strategies used by Ranbaxy
with respect to ‘Histac’ tab.
To find out various promotional strategies used by
Ranbaxy to acquire market share in Nagpur city.
To study the competitors of ‘Histac’ in pharma
market.
To study the perceptions of Doctors on sales of ‘Histac’

 LIMITATIONS:-

The scope of study is limited to Nagpur City only.

There may be discrepancies in the actual data and
the recorded data due to misinterpretations.
Topic is vast but availability of information and
timeline is short.
Unable to meet the decision maker of the
organization.




 SALES PROMOTION

Definition:-
 Sales promotion can be defined as an activity taken
up to boost the sales of a product.


Purpose of Sales promotion:-



Encourage the customers to try a new product.

Attract new customers
Encourage the customers to use the product or
service and make them brand loyal.



 INDUSTRY PROFILE

The Indian Pharmaceutical Industry today is in the

front rank of India’s science-based industries .
The Indian Pharma Industry is estimated to be
worth $ 4.5 billion, growing at about 8 to 9
percent annually.
The Indian Pharmaceutical sector is highly
fragmented with more than 20,000 registered
units
Several Indian pharmaceutical companies have
acquired companies in the US and Europe and
many others .
 COMPANY PROFILE

Ranbaxy Laboratories Limited, India's largest

pharmaceutical company
Ranked 8th amongst the global generic pharmaceutical
companies
The Company has a global footprint in 49 countries,
world-class manufacturing facilities in 11 countries
and serves customers in over 125 countries.
For the year 2008, the Company recorded Global Sales
of US $ 1,682 Mn,
R&D has a pool of over 1,200 scientists engaged in
research.

 SWOT ANALYSIS

 STRENGTHS WEAKNESS

Low cost of production. Low technology level of

Capital Goods of this
Efficient technologies section.
for large number of Very low key R&D.
Generics.
Very low level of
Large pool of skilled Biotechnology for New
technical manpower. Drug Discovery
Systems
 SWOT ANALYSIS cont…

OPPORTUNITY THREATS


 Growing attention for health.  High Cost of discovering new

products and fewer
discoveries.
 New therapy approaches.

 Stricter registration
 Globalization procedures.


 Growing incomes.  High entry cost in newer

markets.
 New diagnoses and new social
diseases.  High cost of sales and
 marketing.

 
 MISSION & VISION STATEMENT OF
RANBAXY LAB.

MISSION:-


“To become a research based international pharmaceutical company”.



VISION:-



 Achieving customer satisfaction is fundamental to our business.


 Provide product and service of the highest quality.



 Manage our operation with high concern for strategy and environment.


 Be a responsible corporate citizen.




 RANITIDINE-150mg

Ranitidine-150 mg is commonly used in treatment of

Peptic Ulcer Disease (PUD) and Gastro Esophageal
Reflux Disease (GERD).

HISTAC:-
 ‘HISTAC’ is a product name of Ranbaxy Brand which
is made up from ‘Ranitidine-150mg’ molecule

 COMPETITORS OF ‘HISTAC’ tab.

PRODUCT NAME COMPANY

ZINETAC GSK
ULTAC CIPLA
ULFAST SUN PHARMA
RANATAC J.B.CHEMECALS
ZORAN DR. REDDY
 THANK YOU…..

